Literature DB >> 32337681

The Role of CARD9 in Metabolic Diseases.

Cheng Tian1, Ya-Li Tuo1, Yi Lu1, Chuan-Rui Xu1, Ming Xiang2.   

Abstract

Caspase recruitment domain containing protein 9 (CARD9) is an adaptor protein that plays a critical role in pattern recognition receptors (PRRs)-mediated activation of NF-?B and mitogen-activated protein kinase (MAPK). This elicits initiation of the pro-inflammatory cytokines and leads to inflammatory responses, which has been recognized as a critical contributor to chronic inflammation. Current researches demonstrate that CARD9 is strongly associated with metabolic diseases, such as obesity, insulin resistance, atherosclerosis and so on. In this review, we summarize CARD9 signaling pathway and the role of CARD9 in metabolic diseases.

Entities:  

Keywords:  caspase recruitment domain containing protein 9; metabolic diseases; pattern recognition receptors

Year:  2020        PMID: 32337681     DOI: 10.1007/s11596-020-2166-4

Source DB:  PubMed          Journal:  Curr Med Sci        ISSN: 2523-899X


  6 in total

Review 1.  CARD9 Regulation and its Role in Cardiovascular Diseases.

Authors:  Haina Zhang; Yeling Wang; Hongbo Men; Wenqian Zhou; Shanshan Zhou; Quan Liu; Lu Cai
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

2.  CARD9-Mediated Signaling and Cardiovascular Diseases.

Authors:  Xuanyou Liu; Bimei Jiang; Hong Hao; Zhenguo Liu
Journal:  JACC Basic Transl Sci       Date:  2022-04-25

Review 3.  CARD9 Signaling, Inflammation, and Diseases.

Authors:  Xuanyou Liu; Bimei Jiang; Hong Hao; Zhenguo Liu
Journal:  Front Immunol       Date:  2022-03-30       Impact factor: 7.561

4.  CARD9 Mediates Pancreatic Islet Beta-Cell Dysfunction Under the Duress of Hyperglycemic Stress.

Authors:  Suhadinie Gamage; Mirabela Hali; Fei Chen; Anjaneyulu Kowluru
Journal:  Cell Physiol Biochem       Date:  2022-04-01

5.  CARD9 mediates glucose-stimulated insulin secretion in pancreatic beta cells.

Authors:  Suhadinie Gamage; Mirabela Hali; Anjaneyulu Kowluru
Journal:  Biochem Pharmacol       Date:  2021-07-04       Impact factor: 6.100

6.  The Cholesterol Metabolite Cholest-5-en-3-One Alleviates Hyperglycemia and Hyperinsulinemia in Obese (db/db) Mice.

Authors:  Koji Nagao; Nao Inoue; Kunio Suzuki; Takeshi Shimizu; Teruyoshi Yanagita
Journal:  Metabolites       Date:  2021-12-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.